{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T04:28:35Z","timestamp":1766377715456,"version":"3.41.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,3,24]],"date-time":"2018-03-24T00:00:00Z","timestamp":1521849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00198-018-4494-9","type":"journal-article","created":{"date-parts":[[2018,3,24]],"date-time":"2018-03-24T15:41:40Z","timestamp":1521906100000},"page":"1637-1642","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effects of once-monthly minodronate versus risedronate in osteoporosis patients with rheumatoid arthritis: a 12-month randomized head-to-head comparison"],"prefix":"10.1007","volume":"29","author":[{"given":"K.","family":"Kumagai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Harigane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Kusayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Tezuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Choe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,24]]},"reference":[{"key":"4494_CR1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11926-012-0253-7","volume":"14","author":"C Deal","year":"2012","unstructured":"Deal C (2012) Bone loss in rheumatoid arthritis: systemic, periarticular, and focal. Curr Rheumatol Rep 14:231\u2013237","journal-title":"Curr Rheumatol Rep"},{"key":"4494_CR2","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00198-010-1319-x","volume":"22","author":"C Roux","year":"2011","unstructured":"Roux C (2011) Osteoporosis in inflammatory joint diseases. Osteoporos Int 22:421\u2013433","journal-title":"Osteoporos Int"},{"key":"4494_CR3","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y","volume":"43","author":"G Haugeberg","year":"2000","unstructured":"Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK (2000) Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis Register. Arthritis Rheum 43:522\u2013530","journal-title":"Arthritis Rheum"},{"key":"4494_CR4","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1002\/1529-0131(200012)43:12<2776::AID-ANR18>3.0.CO;2-N","volume":"43","author":"G Haugeberg","year":"2000","unstructured":"Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK (2000) Reduced bone mineral density in male rheumatoid arthritis patients: frequencies and associations with demographic and disease variables in ninety-four patients in the Oslo County Rheumatoid Arthritis Register. Arthritis Rheum 43:2776\u20132784","journal-title":"Arthritis Rheum"},{"key":"4494_CR5","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1002\/art.22117","volume":"54","author":"TP Staa van","year":"2006","unstructured":"van Staa TP, Geusens P, Bijlsma JW, Leufkens HG, Cooper C (2006) Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 54:3104\u20133112","journal-title":"Arthritis Rheum"},{"key":"4494_CR6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00198-016-3769-2","volume":"28","author":"CA Zerbini","year":"2017","unstructured":"Zerbini CA, Clark P, Mendez-Sanchez L, Pereira RM, Messina OD, Una CR, Adachi JD, Lems WF, Cooper C, Lane NE (2017) Biologic therapies and bone loss in rheumatoid arthritis. Osteoporos Int 28:429\u2013446","journal-title":"Osteoporos Int"},{"key":"4494_CR7","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00198-014-2911-2","volume":"26","author":"K Ochi","year":"2015","unstructured":"Ochi K, Inoue E, Furuya T, Ikari K, Toyama Y, Taniguchi A, Yamanaka H, Momohara S (2015) Ten-year incidences of self-reported non-vertebral fractures in Japanese patients with rheumatoid arthritis: discrepancy between disease activity control and the incidence of non-vertebral fracture. Osteoporos Int 26:961\u2013968","journal-title":"Osteoporos Int"},{"key":"4494_CR8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1517\/14656566.2015.997709","volume":"16","author":"JN Hoes","year":"2015","unstructured":"Hoes JN, Bultink IE, Lems WF (2015) Management of osteoporosis in rheumatoid arthritis patients. Expert Opin Pharmacother 16:559\u2013571","journal-title":"Expert Opin Pharmacother"},{"key":"4494_CR9","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.bone.2009.02.016","volume":"44","author":"H Hagino","year":"2009","unstructured":"Hagino H, Nishizawa Y, Sone T, Morii H, Taketani Y, Nakamura T, Itabashi A, Mizunuma H, Ohashi Y, Shiraki M, Minamide T, Matsumoto T (2009) A double-blinded head-to-head trial of minodronate and alendronate in women with postmenopausal osteoporosis. Bone 44:1078\u20131084","journal-title":"Bone"},{"key":"4494_CR10","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s00198-008-0816-7","volume":"20","author":"T Matsumoto","year":"2009","unstructured":"Matsumoto T, Hagino H, Shiraki M, Fukunaga M, Nakano T, Takaoka K, Morii H, Ohashi Y, Nakamura T (2009) Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study. Osteoporos Int 20:1429\u20131437","journal-title":"Osteoporos Int"},{"key":"4494_CR11","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s00774-013-0439-8","volume":"31","author":"H Hagino","year":"2013","unstructured":"Hagino H, Shiraki M, Fukunaga M, Nakano T, Takaoka K, Ohashi Y, Nakamura T, Matsumoto T (2013) Number and severity of prevalent vertebral fractures and the risk of subsequent vertebral fractures in Japanese women with osteoporosis: results from the minodronate trial. J Bone Miner Metab 31:544\u2013550","journal-title":"J Bone Miner Metab"},{"key":"4494_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11657-012-0109-9","volume":"7","author":"H Orimo","year":"2012","unstructured":"Orimo H, Nakamura T, Hosoi T, Iki M, Uenishi K, Endo N, Ohta H, Shiraki M, Sugimoto T, Suzuki T, Soen S, Nishizawa Y, Hagino H, Fukunaga M, Fujiwara S (2012) Japanese 2011 guidelines for prevention and treatment of osteoporosis\u2014executive summary. Arch Osteoporos 7:3\u201320","journal-title":"Arch Osteoporos"},{"key":"4494_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"4494_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.afos.2016.07.002","volume":"2","author":"M Kamimura","year":"2016","unstructured":"Kamimura M, Nakamura Y, Ikegami S, Komatsu M, Uchiyama S, Kato H (2016) Monthly minodronate inhibits bone resorption to a greater extent than does monthly risedronate. Osteoporos Sarcopenia 2:170\u2013174","journal-title":"Osteoporos Sarcopenia"},{"key":"4494_CR15","first-page":"S5","volume":"18","author":"JWG Jacobs","year":"2000","unstructured":"Jacobs JWG, de Nijs RNJ, Lems WF, Bijlsma JWJ (2000) Bone metabolism in rheumatoid arthritis. Clin Exp Rheumatol 18:S5\u2013S11","journal-title":"Clin Exp Rheumatol"},{"key":"4494_CR16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jbspin.2005.10.019","volume":"73","author":"V Breuil","year":"2006","unstructured":"Breuil V, Euller-Ziegler L (2006) Bisphosphonate therapy in rheumatoid arthritis. Joint Bone Spine 73:349\u2013354","journal-title":"Joint Bone Spine"},{"key":"4494_CR17","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/art.1780390307","volume":"39","author":"F Eggelmeijer","year":"1996","unstructured":"Eggelmeijer F, Papapoulos SE, van Paassen HC, Dijkmans BA, Valkema R, Westedt ML, Landman JO, Pauwels EK, Breedveld FC (1996) Increased bone mass with pamidronate treatment in rheumatoid arthritis. Results of a three-year randomized, double-blind trial. Arthritis Rheum 39:396\u2013402","journal-title":"Arthritis Rheum"},{"key":"4494_CR18","doi-asserted-by":"publisher","first-page":"e80890","DOI":"10.1371\/journal.pone.0080890","volume":"8","author":"Z Feng","year":"2013","unstructured":"Feng Z, Zeng S, Wang Y, Zheng Z, Chen Z (2013) Bisphosphonates for the prevention and treatment of osteoporosis in patients with rheumatic diseases: a systematic review and meta-analysis. PLoS One 8:e80890","journal-title":"PLoS One"},{"key":"4494_CR19","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00198-015-3369-6","volume":"27","author":"K Ebina","year":"2016","unstructured":"Ebina K, Noguchi T, Hirao M, Hashimoto J, Kaneshiro S, Yukioka M, Yoshikawa H (2016) Effects of switching weekly alendronate or risedronate to monthly minodronate in patients with rheumatoid arthritis: a 12-month prospective study. Osteoporos Int 27:351\u2013359","journal-title":"Osteoporos Int"},{"key":"4494_CR20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0022-3565(24)38786-5","volume":"296","author":"JE Dunford","year":"2001","unstructured":"Dunford JE, Thompson K, Coxon FP, Luckman SP, Hahn FM, Poulter CD, Ebetino FH, Rogers MJ (2001) Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J Pharmacol Exp Ther 296:235\u2013242","journal-title":"J Pharmacol Exp Ther"},{"key":"4494_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.bone.2011.03.774","volume":"49","author":"FH Ebetino","year":"2011","unstructured":"Ebetino FH, Hogan AM, Sun S, Tsoumpra MK, Duan X, Triffitt JT, Kwaasi AA, Dunford JE, Barnett BL, Oppermann U, Lundy MW, Boyde A, Kashemirov BA, McKenna CE, Russell RG (2011) The relationship between the chemistry and biological activity of the bisphosphonates. Bone 49:20\u201333","journal-title":"Bone"},{"key":"4494_CR22","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1517\/13543776.11.9.1371","volume":"11","author":"H Fleisch","year":"2001","unstructured":"Fleisch H (2001) Bisphosphonates: mechanisms of action. Expert Opin Ther Pat 11:1371\u20131381","journal-title":"Expert Opin Ther Pat"},{"key":"4494_CR23","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00296-005-0042-y","volume":"26","author":"K Yamamoto","year":"2006","unstructured":"Yamamoto K, Yoshino S, Shue G, Nagashima M (2006) Inhibitory effect of bone resorption and inflammation with etidronate therapy in patients with rheumatoid arthritis for 3 years and in vitro assay in arthritis models. Rheumatol Int 26:627\u2013632","journal-title":"Rheumatol Int"},{"key":"4494_CR24","first-page":"407","volume":"35","author":"M Morishita","year":"2008","unstructured":"Morishita M, Nagashima M, Wauke K, Takahashi H, Takenouchi K (2008) Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results. J Rheumatol 35:407\u2013413","journal-title":"J Rheumatol"},{"key":"4494_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00774-003-0458-y","volume":"22","author":"Y Ogura","year":"2004","unstructured":"Ogura Y, Gonsho A, Cyong JC, Orimo H (2004) Clinical trial of risedronate in Japanese volunteers: single and multiple oral dose studies. J Bone Miner Metab 22:111\u2013119","journal-title":"J Bone Miner Metab"},{"key":"4494_CR26","first-page":"83","volume":"11","author":"J Reginster","year":"2000","unstructured":"Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML, Lund B, Ethgen D, Pack S, Roumagnac I, Eastell R (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy Risedronate Ther (VERT) Study Group Osteoporos Int 11:83\u201391","journal-title":"Vertebral Efficacy Risedronate Ther (VERT) Study Group Osteoporos Int"},{"key":"4494_CR27","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s001980200135","volume":"13","author":"M Fukunaga","year":"2002","unstructured":"Fukunaga M, Kushida K, Kishimoto H, Shiraki M, Taketani Y, Minaguchi H, Inoue T, Morita R, Morii H, Yamamoto K, Ohashi Y, Orimo H (2002) A comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trial. Osteoporos Int 13:971\u2013979","journal-title":"Osteoporos Int"},{"key":"4494_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bone.2013.10.017","volume":"59","author":"H Hagino","year":"2014","unstructured":"Hagino H, Kishimoto H, Ohishi H, Horii S, Nakamura T (2014) Efficacy, tolerability and safety of once-monthly administration of 75mg risedronate in Japanese patients with involutional osteoporosis: a comparison with a 2.5mg once-daily dosage regimen. Bone 59:44\u201352","journal-title":"Bone"},{"key":"4494_CR29","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1007\/s00198-011-1782-z","volume":"23","author":"R Okazaki","year":"2012","unstructured":"Okazaki R, Hagino H, Ito M, Sone T, Nakamura T, Mizunuma H, Fukunaga M, Shiraki M, Nishizawa Y, Ohashi Y, Matsumoto T (2012) Efficacy and safety of monthly oral minodronate in patients with involutional osteoporosis. Osteoporos Int 23:1737\u20131745","journal-title":"Osteoporos Int"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-018-4494-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-018-4494-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-018-4494-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:43:47Z","timestamp":1751499827000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-018-4494-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,24]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["4494"],"URL":"https:\/\/doi.org\/10.1007\/s00198-018-4494-9","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"type":"print","value":"0937-941X"},{"type":"electronic","value":"1433-2965"}],"subject":[],"published":{"date-parts":[[2018,3,24]]},"assertion":[{"value":"20 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol and publication were approved by the Institutional Review Board at Yokohama City University (no. B120510026). This study was conducted in accordance with the Declaration of Helsinki and written informed consent was obtained from all subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}